Showing 6,928 results

Filters Content type: News, Editors' picks Country: United States
Access to healthcare

Tackling the high price of medicine

Editor's pick
Daily Maverick
15 April 2019
Pharmaceutical industry

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Editor's pick
The Body
15 April 2019
Injectable & long-acting HIV treatment

Jose Arribas, MD, on the Challenges That Come With Long-Acting Injectables

Editor's pick
Contagion Live
15 April 2019
Side effects

Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs

Editor's pick
Associated Press
12 April 2019
How HIV works

New study reveals HIV’s vulnerabilities, opening up possibilities for complementary therapies

Editor's pick
STAT
11 April 2019
Starting treatment

US regulators approve new two-drug combination pill for HIV

News
11 April 2019
Migrants, refugees & displaced people

Autopsy: Migrant detainee died from AIDS complications

Editor's pick
San Francisco Chronicle
10 April 2019
Government, leadership & policy

US: How HHS Secretary Alex Azar Reconciles Medicaid Cuts With Stopping The Spread Of HIV

Editor's pick
NPR
9 April 2019
Hepatitis & HIV

Summary from CROI 2019 for viral Hepatitis, from Jürgen Rockstroh

Editor's pick
NATAP
9 April 2019
PrEP science

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

Editor's pick
The Body
9 April 2019
People & personal stories

Gregg Gonsalves Blends Activism and Science

Editor's pick
The New York Times
9 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
Opportunistic infections

A Mysterious Infection, Spanning the Globe in a Climate of Secrecy

Editor's pick
New York Times
8 April 2019
PrEP science

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

Editor's pick
Gilead press release
8 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
Activism & civil society

8 Advocates Share Their Top HIV Policy Issues at AIDSWatch 2019

Editor's pick
The Body
5 April 2019
Men who have sex with men (MSM)

The Unfinished Business of HIV: 2018 Annual Report

Editor's pick
MPact Global Action for Gay Men’s Health and Rights
5 April 2019
Confidentiality, consent & medical ethics

Inside Grindr, fears that China wanted to access user data via HIV research

Editor's pick
NBC News
5 April 2019
Treatment simplification strategies

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks

Editor's pick
ViiV press release
5 April 2019
Elimination of hepatitis C

San Francisco Study Shows Engagement in HCV Care Aids Elimination

Editor's pick
Infectious Disease Advisor
2 April 2019
Ethnic & cultural minorities

HIV hitting Latino men in California at an alarming rate

Editor's pick
The Monitor
1 April 2019
Transgender people

Ten Black Transgender Women to Watch

Editor's pick
TheBody.com
1 April 2019
Transgender people

King's College Hospital launches first transgender sexual health service for South London

Editor's pick
King's College Hospital
1 April 2019
Men who have sex with men (MSM)

Arizona sued over 'No Promo Homo' school sex-ed curriculum

Editor's pick
AZ Central
29 March 2019